P3 Health Partners Inc

P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The firm offers capital efficient care model, data and technology, physician leadership and community outreach tools to create enhanced patient outcomes and experiences. The company was founded by Sherif Abdou and Amir Bacchus on August 20, 2020 and is headquartered in Henderson, NV.

Earnings data Q1 2024

PIII updates 2023 guidance, sees growth in value-based care

PIII reports improved financial performance, increased persistent lives served, and improved medical margin. The company expresses confidence in its performance and updates the full-year 2023 adjusted EBITDA guidance to reflect improved business performance. Analysts inquire about factors driving the company's confidence, the impact of transitioning from a COVID-influenced environment, and various performance drivers.

P3 Health Partners Achieves Positive Q2 EBITDA and Expands Operations

P3 Health Partners delivered a strong performance in Q2 2023, with positive adjusted EBITDA, improved medical margin, and significant cost reductions. The company's expansion and onboarding of Medicare risk lives position it for continued growth and improved financial results.

PIII reports Q3 EBITDA impact, reaffirms '23 guidance, and provides '24 outlook

PIII's Q3 performance was impacted by timing elements, but it showcased strong top-line results and progress in key financial metrics. The company reaffirmed guidance for '23 and provided positive preliminary guidance for '24, emphasizing efficiency and ongoing growth opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11, 2024, at 1:30 pm Eastern Time. A webcast of the presentation will be available on P3's Investor Relations Website: https://ir.p3hp.org/. A replay will be available on P3's investor relations webpage for 30 d.

P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference

P3 Health Partners Inc. (PIII) Q4 2023 Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2023, and affirmed its 2024 guidance. “Top line results for 2023 were strong as the team executed and delivered with revenue of approximately $1.27 billion, representing 21% growth and exceeding the top end of our guidance range. We.

P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for the fourth quarter and full year 2023 on March 28, 2024 and is reaffirming its 2024 guidance. The Company expects to file its Annual Report on Form 10-K for the year ended December 31, 2023, with the SEC within the extension period provided by Rule 12b-25.

P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that leadership is scheduled to present at the KeyBanc LifeSciences & Medtech Investor Forum virtually on Tuesday, March 19, 2024 at 3:45pm ET. A webcast of the presentation will be available on P3's Investor Relations Website: https://ir.p3hp.org/. A replay will be available on P3's investor relations we.

P3 Health Partners to Present at the KeyBanc LifeSciences & Medtech Investor Forum

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced management will participate in the upcoming Jefferies Value Based Healthcare Summit in Miami Beach, Florida. Management is scheduled to host investor meetings on Monday, March 11th, 2024. About P3 Health Partners (NASDAQ: PIII): P3 Health Partners Inc. is a leading population health management company committed to transformin.

P3 Health Partners to Participate in the Jefferies Value Based Healthcare Summit

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the TD Cowen 44th Annual Health Care Conference in Boston on Monday, March 4, 2024 at 10:30 am Eastern Time. A webcast of the fireside chat will be available on P3's Investor Relations Website: https://ir.p3hp.org/. A replay will be available on P3's investor relations webpage for 30.

P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conference

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah. Management is scheduled to host investor meetings on Tuesday, February 13th, and Wednesday February 14th, 2024. About P3 Health Partners (NASDAQ: PIII): P3 Health Partners Inc. is a lea.

P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

P3 Health Partners shares jumped in Wednesday premarket trading after the healthcare company guided for a strong rise in 2024 revenue and positive underlying earnings (EBITDA) as it grows its Medicare Advantage member base. In an update ahead of a presentation at a J.P.

P3 Health Partners stock pops on bullish 2024 revenue guidance

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, is participating in J.P. Morgan's 42nd Annual Healthcare Conference, being held in San Francisco, CA from January 8-11, 2024. In advance of the associated meetings and presentation, P3 is reaffirming guidance for 2023 and announcing guidance for 2024. “We made significant strides in 2023 and expect to achieve meaningful prof.

P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024

Clover Health Investments

Talkspace

Zacks Medical Info Systems industry stocks like Clover Health Investments (CLOV), Talkspace (TALK) and P3 Health Partners (PIII) are expected to gain from the new normal trends.

3 Medical Info Systems Stocks to Buy as Industry Rebounds

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that it will participate at the upcoming J.P. Morgan Healthcare Conference in San Francisco, California. Management will give a presentation on Wednesday, January 10, 2024, at 1:30 PM Pacific Time. A webcast of the live event will be available on the P3 Investor Relations website at ir.p3hp.org. A replay will be available shortly a.

P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that leadership will participate in the BTIG Digital Health Forum, being held virtually, on Monday, November 20, 2023, including a panel discussion with Dr. Sherif Abdou, Chief Executive Officer and Co-founder of P3, at 12:00 p.m. PT/3:00 p.m. ET. About P3 Health Partners (NASDAQ: PIII): P3 Health Partners In.

P3 Health Partners to Present at the BTIG Digital Health Forum

P3 Health Partners Inc. (NASDAQ:PIII ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Corporate Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer & Co-Founder Bill Bettermann - Chief Operating Officer Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Gary Taylor - TD Cowen Ryan Daniels - William Blair Jenny Shen - BTIG Operator Good afternoon, everyone, and welcome to the P3 Health Partners Third Quarter Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

P3 Health Partners Inc. (PIII) Q3 2023 Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2023. “Our results for the third quarter show the continued improvement of the business as providers and patients mature on our platform. All key metrics are tracking as expected and net cash used in operating activities has improved to negative.

P3 Health Partners Announces Third-Quarter and Year-to-Date 2023 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for third-quarter 2023 and file its Quarterly Report on Form 10-Q on Wednesday, November 8, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health Thi.

P3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference Call

Augmedix

Zacks Medical Info Systems industry stocks like P3 Health Partners (PIII), Talkspace (TALK) and Augmedix (AUGX) are expected to gain from the new normal trends.

3 Medical Info Systems Stocks to Buy as Industry Trends Improve

Globalstar

Senseonics Holdings

The allure of penny stocks is undeniable. Their low price point, combined with the potential for high returns, makes them a tantalizing option for investors.

3 Top Penny Stocks To Buy Now According To Insiders

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that it will participate in the Lake Street Best Ideas Growth Conference in New York, New York on Thursday, September 14th, 2023. About P3 Health Partners (NASDAQ: PIII): P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the lives of both pat.

P3 Health Partners to Participate in the Lake Street Best Ideas Growth Conference

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that it will participate at the upcoming Wells Fargo Healthcare Conference in Boston, Massachusetts. Management will give a presentation on Thursday, September 7th, 2023, at 4:30 PM Eastern Time. A webcast of the live event will be available on the P3 Investor Relations website at ir.p3hp.org. A replay will be avai.

P3 Health Partners to Present at Wells Fargo Healthcare Conference

P3 Health Partners Inc. (PIII) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Here's Why P3 Health Partners Inc. (PIII) is Poised for a Turnaround After Losing -28.57% in 4 Weeks

P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Karen Blomquist - Vice President, Investor Relations Sherif Abdou - Chief Executive Officer & Co-Founder Bill Bettermann - Chief Operating Officer Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Joshua Raskin - Nephron Research Ryan Daniels - William Blair Gary Taylor - TD Cowen Brooks O'Neil - Lake Street Capital Markets Operator Hello, and welcome to the P3 Health Partners Q2 2023 Earnings Call. [Operator Instructions] Please note, today's event is being recorded.

P3 Health Partners Inc. (PIII) Q2 2023 Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2023. “The results for the second quarter of 2023 show the power and trajectory of the P3 model. I'm delighted to say we had solid improvement across all key metrics. The strength we have seen in 2023 has given us the stability and momentum to drive.

P3 Health Partners Announces Second-Quarter 2023 Results

NEW YORK , Aug. 1, 2023 /PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of P3 Health Partners Inc. (NASDAQ: PIII). If you are a shareholder of P3 Health Partners Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at: https://pjlfirm.com/p3-health-partners-inc/ You may also contact Robert H.

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating P3 Health Partners Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, announces that the Company plans to release its financial results for second-quarter 2023 and file its quarterly report on Form 10-Q on Monday, August 7, 2023. In connection with this release, management will host a conference call and webcast to provide a corporate and financial update: Title & Webcast P3 Health Second-.

News for P3 Health Partners Inc Stock (PIII)